Log InSign Up
Who We Serve
What We Do
Insights
About

Browse unicorn companies

Discover private companies that have reached unicorn status. Register today to add companies to your watchlist and stay up to date on pricing and financing information, and discover how Forge may help you buy and sell private shares of these companies.

Last Funding Round (LFR)
Company Sector & Subsector Forge Price1 Forge Price Change2 Share Class Post-Money Valuation3 Price per Share Amount Raised
Mammoth BiosciencesMammoth BiosciencesHealthcare
Biotech & Pharma
----Series D-2$1.35B$xx.xx$107.74MM
OwkinOwkinHealthcare
Biotech & Pharma
----Series B-1$1.46B$xx.xx$50MM
Prime MedicinePrime MedicineHealthcare
Biotech & Pharma
----Series B$1.23B$xx.xx$200MM
ArsenalBioArsenalBioHealthcare
Biotech & Pharma
----Series C$1.66B$xx.xx$327.5MM
10x Genomics, Inc.10x Genomics, Inc.Healthcare
Biotech & Pharma
----Series D-1$1.34B$xx.xx$35MM
BillionToOneBillionToOneHealthcare
Biotech & Pharma
----Series D$1.25B$xx.xx$130.47MM
Ginkgo BioworksGinkgo BioworksHealthcare
Biotech & Pharma
----Series E$4.89B$xx.xx$360MM
FreenomeFreenomeHealthcare
Biotech & Pharma
----Series F$2.17B$xx.xx$254MM
Areteia TherapeuticsAreteia TherapeuticsHealthcare
Biotech & Pharma
----Series A-2$1.55B$xx.xx$58.74MM
InsitroInsitroHealthcare
Biotech & Pharma
----Series C$2.57B$xx.xx$400MM
MedableMedableHealthcare
Biotech & Pharma
----Series D$2.1B$xx.xx$304.88MM
Element BiosciencesElement BiosciencesHealthcare
Biotech & Pharma
----Series D-1$1.05B$xx.xx$138.5MM
Eikon TherapeuticsEikon TherapeuticsHealthcare
Biotech & Pharma
----Series D$1.45B$xx.xx$400MM
Orca BioOrca BioHealthcare
Biotech & Pharma
----Series E$1.2B$xx.xx$125MM
Generate:BiomedicinesGenerate:BiomedicinesHealthcare
Biotech & Pharma
----Series C$1.95B$xx.xx$288MM
ImmunaiImmunaiHealthcare
Biotech & Pharma
----Series C-1$1.15B$xx.xx$204.34MM
Formation BioFormation BioHealthcare
Biotech & Pharma
----Series D$1.48B$xx.xx$372MM
GrailGrailHealthcare
Biotech & Pharma
----Series D$4.26B$xx.xx$392.01MM
SynthegoSynthegoHealthcare
Biotech & Pharma
----Series E$1.3B$xx.xx$144.17MM
Intarcia TherapeuticsIntarcia TherapeuticsHealthcare
Biotech & Pharma
----Series EE$3.94B$xx.xx$475.68MM
Xaira TherapeuticsXaira TherapeuticsHealthcare
Biotech & Pharma
----Series A$2.65B$xx.xx$500MM
AsimovAsimovHealthcare
Biotech & Pharma
----Series B$1.24B$xx.xx$175MM
Nutcracker TherapeuticsNutcracker TherapeuticsHealthcare
Biotech & Pharma
----Series C$1.09B$xx.xx$167.76MM
Proteus Digital HealthProteus Digital HealthHealthcare
Biotech & Pharma
----Series H$1.64B$xx.xx$50MM

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered